Were there any dosing on the AZN /Bavi NSCLC trial or is it shelved?
1) One person asked for the AVID III site but it wasn't disclosed.
2) The MSK results are pre-clinical (but I think we expected that to be the case) but they didn't disclose the conference(s).
3) Another one tried to find out what the 'several solid cancers' for Durvalumab+Bavituximab would be besides those they already disclosed (that was on my request because I expect several to be more then two or three). No info, but between the lines - and that is a big maybe - NSCLC could be part of it. ATTENTION: As I understood it that HAS NOT been said by PPHM but seems more like a deduction.
4) No comments on collaboration/partner talks.
Well it is no longer like some time ago were almost everything could be known :) Several leak sources have been duly closed.
Market Data 
Markets 
AI
